Cardiol Therapeutics (CRDL) Retained Earnings (2020 - 2026)
Cardiol Therapeutics' (CRDL) quarterly Retained Earnings came in at -$163.3 million in Q1 2026, down 24.91% YoY from -$217.4 million in Q1 2025, and down 6.85% on a QoQ basis from -$152.8 million in Q4 2025.
Cardiol Therapeutics (CRDL) Retained Earnings (2020 - 2026) Analysis & Trends
Cardiol Therapeutics (CRDL) has 7 years of Retained Earnings data on file, last reported at -$163.3 million in Q1 2026.
- Quarterly Retained Earnings fell 24.91% year-over-year to -$163.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$163.3 million (down 24.91% YoY) and the FY2025 annual result came in at -$152.8 million, down 19.07% from the prior year.
- Retained Earnings eased to -$163.3 million in Q1 2026, from -$152.8 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$73.0 million in Q1 2022 to a low of -$163.3 million in Q1 2026.
- A 5-year average of -$113.4 million and a median of -$112.6 million in 2024 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings plunged 41.66% — and 2025, when it decreased 16.05%.
- Tracing CRDL's Retained Earnings over 5 years: stood at -$84.3 million in 2022, then slipped by 24.21% to -$104.7 million in 2023, then slipped by 22.53% to -$128.3 million in 2024, then slipped by 19.07% to -$152.8 million in 2025, then slipped by 6.85% to -$163.3 million in 2026.
- The last three Retained Earnings figures came in at -$163.3 million (Q1 2026), -$152.8 million (Q4 2025), and -$149.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 3.75 Bn |
| 10 | Cardiol Therapeutics | 214.93 Mn | 196.07 Mn | - | -166.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -163.26 Mn |
| Dec 31, 2025 | -152.79 Mn |
| Sep 30, 2025 | -149.62 Mn |
| Jun 30, 2025 | -141.38 Mn |
| Mar 31, 2025 | -130.70 Mn |
| Dec 31, 2024 | -128.32 Mn |
| Sep 30, 2024 | -125.86 Mn |
| Jun 30, 2024 | -115.77 Mn |
| Mar 31, 2024 | -112.62 Mn |
| Dec 31, 2023 | -104.73 Mn |
| Sep 30, 2023 | -100.66 Mn |
| Jun 30, 2023 | -96.04 Mn |
| Mar 31, 2023 | -89.90 Mn |
| Dec 31, 2022 | -84.31 Mn |
| Sep 30, 2022 | -81.99 Mn |
| Jun 30, 2022 | -77.62 Mn |
| Mar 31, 2022 | -73.00 Mn |
| Dec 31, 2021 | -66.26 Mn |
| Sep 30, 2021 | -61.38 Mn |
| Jun 30, 2021 | -54.79 Mn |